123 related articles for article (PubMed ID: 38560761)
1. Photodynamic Therapy with Targeted Release of Boron-Dipyrromethene Dye from Cobalt(III) Prodrugs in Red Light.
Jana A; Sahoo S; Paul S; Sahoo S; Jayabaskaran C; Chakravarty AR
Inorg Chem; 2024 Apr; 63(15):6822-6835. PubMed ID: 38560761
[TBL] [Abstract][Full Text] [Related]
2. Lysosome directed red light photodynamic therapy using glycosylated iron-(III) conjugates of boron-dipyrromethene.
Sahoo S; Pathak S; Kumar A; Nandi D; Chakravarty AR
J Inorg Biochem; 2023 Jul; 244():112226. PubMed ID: 37105008
[TBL] [Abstract][Full Text] [Related]
3. Cobalt(III) Complexes for Light-Activated Delivery of Acetylacetonate-BODIPY, Cellular Imaging, and Photodynamic Therapy.
Jana A; Kundu P; Paul S; Kondaiah P; Chakravarty AR
Inorg Chem; 2022 May; 61(18):6837-6851. PubMed ID: 35471858
[TBL] [Abstract][Full Text] [Related]
4. Pyriplatin-Boron-Dipyrromethene Conjugates for Imaging and Mitochondria-Targeted Photodynamic Therapy.
Raza MK; Gautam S; Howlader P; Bhattacharyya A; Kondaiah P; Chakravarty AR
Inorg Chem; 2018 Nov; 57(22):14374-14385. PubMed ID: 30376306
[TBL] [Abstract][Full Text] [Related]
5. Ruthenium(II) Conjugates of Boron-Dipyrromethene and Biotin for Targeted Photodynamic Therapy in Red Light.
Paul S; Kundu P; Bhattacharyya U; Garai A; Maji RC; Kondaiah P; Chakravarty AR
Inorg Chem; 2020 Jan; 59(1):913-924. PubMed ID: 31825210
[TBL] [Abstract][Full Text] [Related]
6. Biotin and boron-dipyrromethene-tagged platinum(IV) prodrug for cellular imaging and mito-targeted photocytotoxicity in red light.
Bera A; Nepalia A; Upadhyay A; Kumar Saini D; Chakravarty AR
Dalton Trans; 2023 Sep; 52(37):13339-13350. PubMed ID: 37671587
[TBL] [Abstract][Full Text] [Related]
7. Curcumin "Drug" Stabilized in Oxidovanadium(IV)-BODIPY Conjugates for Mitochondria-Targeted Photocytotoxicity.
Bhattacharyya U; Kumar B; Garai A; Bhattacharyya A; Kumar A; Banerjee S; Kondaiah P; Chakravarty AR
Inorg Chem; 2017 Oct; 56(20):12457-12468. PubMed ID: 28972748
[TBL] [Abstract][Full Text] [Related]
8. Oxoplatin-B, a cisplatin-based platinum(IV) complex with photoactive BODIPY for mitochondria specific "chemo-PDT" activity.
Bera A; Gautam S; Raza MK; Kondaiah P; Chakravarty AR
J Inorg Biochem; 2021 Oct; 223():111526. PubMed ID: 34246120
[TBL] [Abstract][Full Text] [Related]
9. BODIPY and 2,3-Dihydrophthalazine-1,4-Dione Conjugates As Heavy Atom-Free Chemiluminogenic Photosensitizers.
Degirmenci A; Sonkaya Ö; Soylukan C; Karaduman T; Algi F
ACS Appl Bio Mater; 2021 Jun; 4(6):5090-5098. PubMed ID: 35007057
[TBL] [Abstract][Full Text] [Related]
10. Mitochondria-Targeting Boron Dipyrromethene Based Photosensitizers for Enhanced Photodynamic Therapy: Synthesis, Optical Properties, and in vitro Biological Activity.
Hu P; Weng XL; Zhu CH; Yang DC; Liu JY; Chen Z; Huang M
Chempluschem; 2022 Sep; 87(9):e202200158. PubMed ID: 36148971
[TBL] [Abstract][Full Text] [Related]
11. BODIPY-attached zinc(II) complexes of curcumin drug for visible light assisted photo-sensitization, cellular imaging and targeted PDT.
Bhattacharyya A; Jameei A; Karande AA; Chakravarty AR
Eur J Med Chem; 2021 Aug; 220():113438. PubMed ID: 33915370
[TBL] [Abstract][Full Text] [Related]
12. BODIPY-Tagged Platinum(II) Curcumin Complexes for Endoplasmic Reticulum-Targeted Red Light PDT.
Upadhyay A; Kundu P; Ramu V; Kondaiah P; Chakravarty AR
Inorg Chem; 2022 Jan; 61(3):1335-1348. PubMed ID: 34990135
[TBL] [Abstract][Full Text] [Related]
13. Glucose-Appended Platinum(II)-BODIPY Conjugates for Targeted Photodynamic Therapy in Red Light.
Ramu V; Gautam S; Garai A; Kondaiah P; Chakravarty AR
Inorg Chem; 2018 Feb; 57(4):1717-1726. PubMed ID: 29400953
[TBL] [Abstract][Full Text] [Related]
14. Endoplasmic Reticulum-Localized Two-Photon-Absorbing Boron Dipyrromethenes as Advanced Photosensitizers for Photodynamic Therapy.
Zhou Y; Cheung YK; Ma C; Zhao S; Gao D; Lo PC; Fong WP; Wong KS; Ng DKP
J Med Chem; 2018 May; 61(9):3952-3961. PubMed ID: 29681157
[TBL] [Abstract][Full Text] [Related]
15. A Platinum(II) Boron-dipyrromethene Complex for Cellular Imaging and Mitochondria-targeted Photodynamic Therapy in Red Light.
Upadhyay A; Nepalia A; Bera A; Saini DK; Chakravarty AR
Chem Asian J; 2023 Nov; 18(21):e202300667. PubMed ID: 37706570
[TBL] [Abstract][Full Text] [Related]
16. Novel ruthenium(ii) and iridium(iii) BODIPY dyes: insights into their application in photodynamic therapy in vitro.
Aksakal NE; Tanrıverdi Eçik E; Kazan HH; Yenilmez Çiftçi G; Yuksel F
Photochem Photobiol Sci; 2019 Aug; 18(8):2012-2022. PubMed ID: 31282525
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure, DNA crosslinking and photo-induced cytotoxicity of oxovanadium(IV) conjugates of boron-dipyrromethene.
Kumar A; Dixit A; Sahoo S; Banerjee S; Bhattacharyya A; Garai A; Karande AA; Chakravarty AR
J Inorg Biochem; 2020 Jan; 202():110817. PubMed ID: 31706182
[TBL] [Abstract][Full Text] [Related]
18. BODIPY-based monofunctional Pt (II) complexes for specific photocytotoxicity against cancer cells.
Qi F; Yuan H; Chen Y; Guo Y; Zhang S; Liu Z; He W; Guo Z
J Inorg Biochem; 2021 May; 218():111394. PubMed ID: 33647541
[TBL] [Abstract][Full Text] [Related]
19. Trifluoromethyl Boron Dipyrromethene Derivatives as Potential Photosensitizers for Photodynamic Therapy.
Liu JY; Zhou PZ; Ma JL; Jia X
Molecules; 2018 Feb; 23(2):. PubMed ID: 29463048
[TBL] [Abstract][Full Text] [Related]
20. Bichromophoric ruthenium(II) bis-terpyridine-BODIPY based photosensitizers for cellular imaging and photodynamic therapy.
Paul S; Pathak S; Sahoo S; Maji RC; Bhattacharyya U; Nandi D; Chakravarty AR
Dalton Trans; 2022 Jul; 51(27):10392-10405. PubMed ID: 35758169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
